These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26201386)

  • 1. What is the intrapatient variability of mycophenolic acid trough levels?
    Todorova EK; Huang SH; Kobrzynski MC; Filler G
    Pediatr Transplant; 2015 Nov; 19(7):669-74. PubMed ID: 26201386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function.
    Pape L; Ehrich JH; Offner G
    Clin Transplant; 2004 Oct; 18(5):576-9. PubMed ID: 15344963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimum mycophenolic acid levels are associated with donor-specific antibody formation.
    Filler G; Todorova EK; Bax K; Alvarez-Elías AC; Huang SH; Kobrzynski MC
    Pediatr Transplant; 2016 Feb; 20(1):34-8. PubMed ID: 26589470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
    Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A
    Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of MMF dose and trough levels on adverse effects in pediatric heart transplant recipients.
    Siddiqi N; Lamour JM; Hsu DT
    Pediatr Transplant; 2015 Sep; 19(6):618-22. PubMed ID: 26082342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation.
    Filler G; Foster J; Berard R; Mai I; Lepage N
    Transplant Proc; 2004 Jun; 36(5):1327-31. PubMed ID: 15251324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil.
    Dipchand AI; Pietra B; McCrindle BW; Rosebrook-Bicknell HL; Boucek MM
    J Heart Lung Transplant; 2001 Oct; 20(10):1035-43. PubMed ID: 11595558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RELATE: Relationship of limited sampling strategy and adverse effects of mycophenolate mofetil in pediatric renal transplant patients.
    Berger I; Haubrich K; Ensom MHH; Carr R
    Pediatr Transplant; 2019 Mar; 23(2):e13355. PubMed ID: 30689262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
    Tönshoff B; David-Neto E; Ettenger R; Filler G; van Gelder T; Goebel J; Kuypers DR; Tsai E; Vinks AA; Weber LT; Zimmerhackl LB
    Transplant Rev (Orlando); 2011 Apr; 25(2):78-89. PubMed ID: 21454065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome.
    Kaplan B
    Curr Med Res Opin; 2006 Dec; 22(12):2355-64. PubMed ID: 17257450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental changes of MPA exposure in children.
    Yoo EC; Alvarez-Elías AC; Todorova EK; Filler G
    Pediatr Nephrol; 2016 Jun; 31(6):975-82. PubMed ID: 26743220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized crossover study to assess the inter- and intrasubject variability of morning mycophenolic acid concentrations from enteric-coated mycophenolate sodium and mycophenolate mofetil in stable renal transplant recipients.
    Tedesco-Silva H; Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Slade A; Schmouder R; Medina-Pestana JO
    Clin Transplant; 2010; 24(4):E116-23. PubMed ID: 20047618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft outcome and mycophenolic acid trough level monitoring in kidney transplantation.
    Sánchez Fructuoso AI; de la Higuera MA; Garcia-Ledesma P; Giorgi M; Ramos F; Calvo N; Pérez-Flores I; Barrientos A
    Transplant Proc; 2009; 41(6):2102-3. PubMed ID: 19715843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Study on Mycophenolic Acid Drug Interactions: Effect of Prednisone, Sirolimus, and Tacrolimus With MPA.
    Alvarez-Elías AC; Yoo EC; Todorova EK; Singh RN; Filler G
    Ther Drug Monit; 2017 Jun; 39(3):220-228. PubMed ID: 28437284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolic acid pharmacokinetics in stable pediatric renal transplantation.
    David-Neto E; Pereira Araujo LM; Sumita NM; Mendes ME; Ribeiro Castro MC; Alves CF; Kakehashi E; Romano P; Yagyu EM; Queiroga M; Nahas WC; Ianhez LE
    Pediatr Nephrol; 2003 Mar; 18(3):266-72. PubMed ID: 12644921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE; Saint-Marcoux F; Staatz CE; Brunet M; Vinks AA; Miura M; Marquet P; Kuypers DR; van Gelder T; Cattaneo D
    Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy.
    Weber LT; Shipkova M; Armstrong VW; Wagner N; Schütz E; Mehls O; Zimmerhackl LB; Oellerich M; Tönshoff B
    Clin Chem; 2002 Mar; 48(3):517-25. PubMed ID: 11861442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.